AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹268 Cr | ₹250 Cr | ₹246 Cr | ₹230 Cr | ₹208 Cr |
What is the latest Total Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹268 Cr |
Mar2024 | ₹250 Cr |
Mar2023 | ₹246 Cr |
Mar2022 | ₹230 Cr |
Mar2021 | ₹208 Cr |
How is Total Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹268 Cr | 7.50 | |
Mar2024 | ₹250 Cr | 1.54 | |
Mar2023 | ₹246 Cr | 6.82 | |
Mar2022 | ₹230 Cr | 10.72 | |
Mar2021 | ₹208 Cr | - |
Compare Total Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹252.6 Cr | 2.2% | -9.4% | -52.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | 2.2% |
-9.4% |
-52.3% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses